As a cardiologist, I have witnessed firsthand the rapid advancements in digital health and artificial intelligence (AI), and their potential to revolutionize patient care. These emerging technologies ...
Cardiovascular disease is the major cause of the rise in maternal death, much of which is due to increased rates of comorbid conditions of obesity, hyperlipidemia, hypertension, and diabetes mellitus.
The goal of the SENIOR RITA trial was to evaluate routine invasive therapy compared with conservative therapy among older patients with non–ST-elevation myocardial infarction. Additionally, the trial ...
Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based ...
Maurizi N, Anthiochos P, Owens A, et al. This study included 3,566 patients with obstructive HCM and 1,832 (51%) of these patients underwent SRT at a mean age of 51 years. The SRT included alcohol ...
The following are key points to remember from a review comparing international clinical practice guideline recommendations for acute pulmonary embolism (PE): ...
Hammersley DJ, Zegard A, Androulakis E, et al. This observational study included patients with nonischemic cardiomyopathy (NICM) from two British tertiary referral hospitals. Subjects underwent ...
The following are key points to remember from a state-of-the-art review on imaging to facilitate ventricular tachycardia (VT) ablation: ...
There is a significant and independent prognostic value of ESC criteria for suspected myocarditis and the updated Lake-Louise criteria (LLC), respectively. ESC criteria were positive in a larger ...
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode one of four, Dr. Jeff Carstens discusses with Drs. Tom Draper and Michael Montgomery steps to developing a ...
Exercise therapy should be started in the early phases of treatment and continued thereafter to diminish declines in cardiorespiratory fitness from cancer therapy. Liposomal anthracycline or ...
This nationwide cohort study reports decreased risks of several serious CV outcomes after COVID-19 vaccination, likely related to the protection of vaccination against severe COVID-19. However, ...